283 related articles for article (PubMed ID: 36244593)
1. Intracellular uropathogenic Escherichia coli are undetectable in urinary bladders after oral mecillinam treatment: An experimental study in a pig model of cystitis.
Stærk K; Grønnemose RB; Palarasah Y; Lund L; Andersen TE
Microb Pathog; 2022 Dec; 173(Pt A):105817. PubMed ID: 36244593
[TBL] [Abstract][Full Text] [Related]
2.
Stærk K; Grønnemose RB; Nielsen TK; Petersen NA; Palarasah Y; Torres-Puig S; Møller-Jensen J; Kolmos HJ; Lund L; Andersen TE
Microbiology (Reading); 2021 Oct; 167(10):. PubMed ID: 34623231
[TBL] [Abstract][Full Text] [Related]
3. Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.
Schwartz DJ; Chen SL; Hultgren SJ; Seed PC
Infect Immun; 2011 Oct; 79(10):4250-9. PubMed ID: 21807904
[TBL] [Abstract][Full Text] [Related]
4. Detection of intracellular bacterial communities in human urinary tract infection.
Rosen DA; Hooton TM; Stamm WE; Humphrey PA; Hultgren SJ
PLoS Med; 2007 Dec; 4(12):e329. PubMed ID: 18092884
[TBL] [Abstract][Full Text] [Related]
5. Uropathogenic
Li ZP; Li J; Li TL; Song ZY; Gong XZ
Front Cell Infect Microbiol; 2024; 14():1322119. PubMed ID: 38638825
[TBL] [Abstract][Full Text] [Related]
6. Bladder infection with uropathogenic
Montalbetti N; Dalghi MG; Bastacky SI; Clayton DR; Ruiz WG; Apodaca G; Carattino MD
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F1-F13. PubMed ID: 34779263
[TBL] [Abstract][Full Text] [Related]
7. Uropathogenic
Stærk K; Andersen MØ; Andersen TE
J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35475768
[TBL] [Abstract][Full Text] [Related]
8. A Murine Model for Escherichia coli Urinary Tract Infection.
Hannan TJ; Hunstad DA
Methods Mol Biol; 2016; 1333():159-75. PubMed ID: 26468108
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
mBio; 2012; 3(1):. PubMed ID: 22318320
[TBL] [Abstract][Full Text] [Related]
10. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
[TBL] [Abstract][Full Text] [Related]
11. Secretory leukocyte protease inhibitor protects against severe urinary tract infection in mice.
Rosen AL; Lint MA; Voelker DH; Gilbert NM; Tomera CP; Santiago-Borges J; Wallace MA; Hannan TJ; Burnham C-AD; Hultgren SJ; Kau AL
mBio; 2024 Feb; 15(2):e0255423. PubMed ID: 38270443
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis of fitness factors in uropathogenic Escherichia coli in a pig urinary tract infection model.
García V; Stærk K; Alobaidallah MSA; Grønnemose RB; Guerra PR; Andersen TE; Olsen JE; Herrero-Fresno A
Microbiol Res; 2022 Dec; 265():127202. PubMed ID: 36167007
[TBL] [Abstract][Full Text] [Related]
13. Vaginal Inoculation of Uropathogenic Escherichia coli during Estrus Leads to Genital and Renal Colonization.
Robinson CK; Saenkham-Huntsinger P; Hanson BS; Adams LG; Subashchandrabose S
Infect Immun; 2022 Apr; 90(4):e0053221. PubMed ID: 35357220
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
[TBL] [Abstract][Full Text] [Related]
15. Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.
Danka ES; Hunstad DA
J Infect Dis; 2015 Apr; 211(7):1164-73. PubMed ID: 25336727
[TBL] [Abstract][Full Text] [Related]
16. Persistence of uropathogenic Escherichia Coli in the bladders of female patients with sterile urine after antibiotic therapies.
Liu SC; Han XM; Shi M; Pang ZL
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):710-715. PubMed ID: 27752899
[TBL] [Abstract][Full Text] [Related]
17. YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration.
Lau ME; Loughman JA; Hunstad DA
Infect Immun; 2012 Dec; 80(12):4123-32. PubMed ID: 22966043
[TBL] [Abstract][Full Text] [Related]
18. Maturation of intracellular Escherichia coli communities requires SurA.
Justice SS; Lauer SR; Hultgren SJ; Hunstad DA
Infect Immun; 2006 Aug; 74(8):4793-800. PubMed ID: 16861667
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.
Smith MA; Weingarten RA; Russo LM; Ventura CL; O'Brien AD
Infect Immun; 2015 Apr; 83(4):1661-73. PubMed ID: 25667267
[TBL] [Abstract][Full Text] [Related]
20. DamX Controls Reversible Cell Morphology Switching in Uropathogenic Escherichia coli.
Khandige S; Asferg CA; Rasmussen KJ; Larsen MJ; Overgaard M; Andersen TE; Møller-Jensen J
mBio; 2016 Aug; 7(4):. PubMed ID: 27486187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
